Identifying SARS-CoV-2 Spike Protein that Elicits Neutralising Antibodies
Together with the local R&D ecosystem, our scientists identified immunogenic targets against the coronavirus spike glycoprotein to provide crucial advances towards the development of diagnostic tools and potential vaccine candidate targets.
Lisa Ng, SIgN
Laurent Rénia, ID Labs
Wang Cheng-I, SIgN
Two linear epitopes on the SARS-CoV-2 spike protein that elicit neutralising antibodies in COVID-19 patients 
Nature Communications
Antibodies against S14P5 and S21P2 linear B-cell epitopes neutralise SARS-CoV-2.
A*STAR celebrates International Women's Day
From groundbreaking discoveries to cutting-edge research, our researchers are empowering the next generation of female science, technology, engineering and mathematics (STEM) leaders.
Get inspired by our #WomeninSTEM